STING agonism overcomes STAT3-mediated immunosuppression and adaptive resistance to PARP inhibition in ovarian cancer
Background Poly (ADP-ribose) polymerase (PARP) inhibition (PARPi) has demonstrated potent therapeutic efficacy in patients with BRCA-mutant ovarian cancer. However, acquired resistance to PARPi remains a major challenge in the clinic.Methods PARPi-resistant ovarian cancer mouse models were generated...
Saved in:
Main Authors: | Changli Qian, Gordon J Freeman, Tao Jiang, Ursula Matulonis, Ziying Lin, Hye-Jung Kim, Anniina Färkkilä, Hua Yu, Xin Cheng, Panagiotis A Konstantinopoulos, Antons Martincuks, Joyce F Liu, Qiwei Wang, Liya Ding, Michael J Kearns, Shaozhen Xie, Inga-Maria Launonen, Thomas M Roberts, Jean J Zhao |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2023-01-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Online Access: | https://jitc.bmj.com/content/11/1/e005627.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Review of the Structural and Dynamic Mechanisms of PPARγ Partial Agonism
by: Alice J. Kroker, et al.
Published: (2015-01-01) -
Molecular Vibration-Activity Relationship in the Agonism of Adenosine Receptors
by: Hyun Keun Chee, et al.
Published: (2013-12-01) -
PPAR𝜹 Agonism for the Treatment of Obesity and Associated Disorders: Challenges and Opportunities
by: Mylène Perreault, et al.
Published: (2008-01-01) -
Chronic GIPR agonism results in pancreatic islet GIPR functional desensitisation
by: Iona Davies, et al.
Published: (2025-02-01) -
Agonism and performance in adolescent football players in informal physical education settings
by: Sara Aliberti, et al.
Published: (2025-01-01)